WASHINGTON, D.C.—Mortality rates from kidney and renal pelvis cancers (KCa) are increased significantly in places with a low population density of physicians, a study showed. This finding is possibly ... Renal & Urology News: Mortality from Renal and Pelvis Cancers Higher in Places with Fewer Docs Mortality from Renal and Pelvis Cancers Higher in Places with Fewer Docs Everyday Health on MSN: Metastatic kidney cancer survival rates: What you need to know Metastatic kidney survival rates don’t predict individual outcomes.
A number of factors, including overall health, tumor characteristics, and response to treatment, influence prognosis and survival. ascopubs.org: LUNAR: Safety and efficacy evaluation of nadofaragene firadenovec instilled into the renal pelvis in subjects with low-grade upper tract urothelial carcinoma—A single-arm ... A phase II study evaluating the efficacy and safety of perioperative enfortumab vedotin plus toripalimab combined with endoscope-based kidney-sparing surgery for patients with high-risk upper tract ... LUNAR: Safety and efficacy evaluation of nadofaragene firadenovec instilled into the renal pelvis in subjects with low-grade upper tract urothelial carcinoma—A single-arm ...
